Kuehn Law Launches Investigation Into TG Therapeutics Leadership

The investigation targets whether leadership at the NASDAQ-listed firm prioritized personal interests over their obligations to shareholders. Kuehn Law is currently soliciting contact from TGTX stockholders to assess the scope of the alleged misconduct and determine if formal litigation is warranted to enforce investor rights.

Those interested in the case are encouraged to reach out to Sophia Anne Silayan for a consultation. The firm operates on a contingency basis, covering all litigation costs without charging investor clients for their participation. Because legal avenues for shareholder recovery are often time-sensitive, the firm is urging stakeholders to act immediately to ensure their interests are represented in any subsequent proceedings.